Tumor study: Injection of
Official title Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
ClinicalTrials.gov ID: NCT07464132
What this study is testing
What is Injection of 68Ga-NI-FAPI?
Injection of 68Ga-NI-FAPI is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for tumor.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study wants to find out if the tracer [68Ga]Ga‑NI‑FAPI‑04 can help doctors detect diseases that involve activated fibroblasts.
- Who it's for
- People who have tumors, certain heart problems, lung scarring, large‑vessel immune diseases, or other conditions linked to fibroblast activation.
- What's involved
- Participants will receive an injection of the tracer and then have a PET/CT scan to image the affected areas.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85. Healthy volunteers may be eligible.
You may be able to join if
- 1: 18-85 years old
- 2: Tumor patients can undergo surgery or biopsy to obtain pathological diagnosis
- 3: Ability to understand and sign informed consent forms
- 4: Expected survival period exceeding 6 months and able to receive follow-up
- 5: Healthy volunteers without chronic medical history of hypertension, diabetes, coronary heart disease, kidney disease, tumor, etc
You likely can't join if
- 1: Pregnant or lactating women
- 2: Patients allergic to research drug ingredients
- 3: Patients with severe liver and kidney dysfunction (blood creatinine levels exceeding 159 μ mol/L)
- 4: Patients who participate in other clinical trials and interfere with the results of this study
- 5: Patients with severe illness who cannot cooperate with the examination
The study team makes the final eligibility decision.
Where it is enrolling
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Beijing, Beijing Municipality, China. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.